$EBF

Ennis Director Sold $441K In Company Stock - Ennis (NYSE:EBF)

Revealing a significant insider sell on May 22, Alejandro Quiroz, Director at Ennis EBF, as per the latest SEC filing. What Happened: According to a Form 4 filing with the U.S. Securities and Exchange Commission on Thursday, Quiroz sold 21,580 shares of Ennis. The total transaction value is ...

Original reporting
Benzinga · Benzinga Insights
Published May 23, 2025, 3:02 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 24, 2025, 12:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ennis Director Sold $441K In Company Stock - Ennis (NYSE:EBF) — source image
Decision brief

The 30-second read

$EBFNeutralLow
01

Why it matters

While notable, insider sales are common and do not necessarily predict stock decline; further analysis of company fundamentals is recommended.

02

Market read

The news has limited immediate trading relevance but should be monitored for additional insider activity or fundamental changes.

03

What to watch

Lack of information on the company's overall financial health, recent earnings, or market conditions limits the interpretation of this sale.

Timing: short-term

Background

The sale was disclosed via SEC Form 4, indicating a routine insider transaction.

Company-level read

Ticker impact

$EBFNeutralMedium confidence
Context

The insider selling activity of Ennis (EBF) is notable but must be interpreted cautiously.

Expected impact

Limited immediate impact; potential slight downward pressure if viewed negatively by the market.

Evidence & confidence

Insider sales can be routine or strategic; without additional context, the impact remains uncertain.

Market effects

The manufacturing and financial markets sectors may experience minimal impact; insider activity is company-specific.

Negligible; no regional effects expected.

Low; company-specific news with limited global implications.

Counterpoint

The insider sale might indicate confidence in the company's future prospects, as insiders may sell for personal reasons unrelated to company performance.

Key entities

  • Ennis, Inc.

    A manufacturer and distributor of business forms, labels, and other print products.

Related articles

$EBFMed

ENNIS, INC. (EBF): Results of Operations and Financial Condition

ENNIS, INC. (EBF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ebf-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE ENNIS, INC. REPORTS RESULTS FOR THE QUARTER ENDED MAY 31, 2026 AND DECLARES QUARTERLY DIVIDEND Midlothian, TX. June 22, 2026 -- Ennis, Inc. (the “Company”), (NYSE: EBF), today reported financial results f

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.

$BKRMed

Baker Hughes (BKR) Lands Multi-Year Contract with Pakistan’s OGDC

Baker Hughes (BKR) secured a multi-year contract with Pakistan's OGDC to enhance production from mature oil and gas fields. The deal involves assessing 120 wells and providing tailored redevelopment plans. Baker Hughes aims to use AI and other technologies to improve flow assurance and restore production. The contract aligns with Baker Hughes' strategy to diversify revenue and reduce reliance on short-term drilling cycles, as evidenced by a 49% YoY increase in orders to $10.5 billion in Q2. Howe

$AAPLMed

Tim Cook Delivered a 2,720% Total Return Over 15 Years. Here's Whether John Ternus Can Do the Same for Apple Investors.

Tim Cook stepped down as Apple CEO after 15 years, delivering 2,720% total returns. New CEO John Ternus faces challenges, including margin pressure from rising memory costs. Apple is set to launch new iPhone models this week. iPhone sales grew over 20% in recent quarters, but management expects slower growth. Apple stock fell on margin concerns despite briefly surpassing $5 trillion.